Policy & Research

Share

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas

Senate Committee on Federal and State Affairs

By Sarah M. Hartsig, M.S. | February 20, 2017

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas

On February 20, 2017, Sarah M. Hartsig, M.S., KHI Senior Analyst, provided neutral testimony on Senate Bill 155 to the Senate Committee on Federal and State Affairs. The bill would, among other things, legalize medical marijuana for a variety of medical conditions.

During the testimony, KHI discussed findings and recommendations from its 2015 health impact assessment (HIA) Potential Health Effects of Legalizing Medical Marijuana in Kansas.

For more information, see the following documents:

  • Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas
  • Executive Summary: Potential Health Effects of Legalizing Medical Marijuana in Kansas
  • Key Findings and Recommendations: Potential Health Effects of Legalizing Medical Marijuana in Kansas
  • Map: Medical Marijuana Laws in the United States (November 2016)